E-LIB Suche - Ergebnisse für: Bidner, Helen

1

Protocol for a randomized, placebo-controlled, double-blind..:

Wolff, Andreas W. ; Bidner, Helen ; Remane, Yvonne...
Frontiers in Aging Neuroscience. 16 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analys..:

Monin, Malte ; Kümmerle, Tim ; Schneider, Jochen...
HIV Research & Clinical Practice. 23 (2022) 1 - p. 15-21 , 2022

Link: https://doi.org/10.1080/..

3

Virologic outcomes of switching to boosted darunavir plus d..:

Wolf, Eva ; Boesecke, Christoph ; Balogh, Annamaria...
AIDS Research and Therapy. 18 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Adequate plasma levels of dolutegravir in combination with ..:

Weidlich, Simon ; Boesecke, Christoph ; Schneider, Jochen...
Journal of Antimicrobial Chemotherapy. 75 (2020) 10 - p. 3082-3084 , 2020

Link: https://doi.org/10.1093/..

5

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Do..:

Lingor, Paul ; Weber, Markus ; Camu, William...
Frontiers in Neurology. 10 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

6

Virologic outcomes of switching to boosted darunavir plus d..:

Wolf, Eva ; Boesecke, Christoph ; Balogh, Annamaria...
https://mediatum.ub.tum.de/1650501. , 2021

Link: https://mediatum.ub.tum...

7

ROCK-ALS: protocol for a randomized, placebo-controlled, do..:

Lingor, Paul ; Weber, Markus ; Catnu, William...
http://dx.doi.org/10.18725/OPARU-38451. , 2021

Link: https://doi.org/10.18725..

8

Virologic outcomes of switching to boosted darunavir plus d..:

Wolf, Eva ; Boesecke, Christoph ; Balogh, Annamaria...
https://repository.publisso.de/resource/frl:6465800. , 2021

Link: https://repository.publi..

9

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Do..:

Lingor, Paul ; Weber, Markus ; Camu, William...
https://resolver.sub.uni-goettingen.de/purl?gro-2/59859. , 2019

Link: https://resolver.sub.uni..

10

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Do..:

Lingor, Paul ; Weber, Markus ; Bidner, Helen...
info:eu-repo/semantics/altIdentifier/issn/1664-2295. , 2019

Link: https://pub.dzne.de/reco..

11

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Do..:

Lingor, Paul ; Weber, Markus ; Camu, William...
https://mediatum.ub.tum.de/1545929. , 2019

Link: https://mediatum.ub.tum...

12

Table_1_Protocol for a randomized, placebo-controlled, doub..:

Andreas W. Wolff ; Helen Bidner ; Yvonne Remane...
doi:10.3389/fnagi.2024.1308577.s001. , 2024

Link: https://doi.org/10.3389/..

13

Table_1_Protocol for a randomized, placebo-controlled, doub..:

Andreas W. Wolff ; Helen Bidner ; Yvonne Remane...
https://figshare.com/articles/dataset/Table_1_Protocol_for_a_randomized_placebo-controlled_double-blind_phase_IIa_study_of_the_safety_tolerability_and_symptomatic_efficacy_of_the_ROCK-inhibitor_Fasudil_in_patients_with_Parkinson_s_disease_ROCK-PD_PDF/25216637. , 2024

Link: https://doi.org/10.3389/..

14

Table_1_Protocol for a randomized, placebo-controlled, doub..:

Andreas W. Wolff ; Helen Bidner ; Yvonne Remane...
doi:10.3389/fnagi.2024.1308577.s001. , 2024

Link: https://doi.org/10.3389/..

15

Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analys..:

Malte Monin ; Tim Kümmerle ; Jochen Schneider...
http://dx.doi.org/10.1080/25787489.2021.2022825. , 2022

Link: https://doi.org/10.1080/..